Coya Therapeutics, Inc. Common Stock Strategic Asset Allocation Index
Coya Therapeutics, Inc. Common Stock strategic asset allocation index. Coya Therapeutics, Inc. Common Stock (COYA) has a Strategic Asset Allocation Index of 0.6% as of June 2023. Strategic assets (PP&E of $79.63K plus long-term investments of $-) total $79.63K, measured against net assets of $13.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Coya Therapeutics, Inc. Common Stock balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Coya Therapeutics, Inc. Common Stock (2021–2021)
Strategic asset allocation index of Coya Therapeutics, Inc. Common Stock from 2021 to 2021. This chart shows how Coya Therapeutics, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 0.6%, representing strategic assets of $79.63K against net assets of $13.25 Million USD. Check tangible net worth ratio of Coya Therapeutics, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Coya Therapeutics, Inc. Common Stock Strategic Asset Allocation Index by Year (2021–2021)
Coya Therapeutics, Inc. Common Stock strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Coya Therapeutics, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see COYA company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.3% | $120.67K | $120.67K | $- | $3.64 Million | — |